SDC1 and infection: Our finding that KSHV efficiently targets CD138+ plasma cells early in infection of tonsil B lymphocytes is particularly intriguing and relevant in the context of KSHV-mediated lymphoproliferative diseases, which often have a plasma cell or plasmablast-like phenotype [24,25].